GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer

GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer

No specific markers have been identified to detect non-small cell lung cancer (NSCLC) cell-derived exosomes circulating in the blood. Here, we report a new biomarker that distinguishes between cancer and non-cancer cell-derived exosomes. Exosomes isolated from patient plasmas at various pathological...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hyesun Jeong, Byeong Hyeon Choi, JinA Park, Jik-Han Jung, Hyunku Shin, Ka-Won Kang, Yu Hua Quan, Jewon Yu, Ji-Ho Park, Yong Park, Yeonho Choi, Hyun Koo Kim, Sunghoi Hong
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
exosomes
non-small cell lung cancer
GCC2
biomarkers
early detection
liquid biopsy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/ec9c5250a33a43519fff7380f8888040
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/ec9c5250a33a43519fff7380f8888040

Documents similaires